nach oben

Current Atherosclerosis Reports

Erschienen in:

01.12.2012 | Nutrition (BV Howard, Section Editor)

Vitamin D and Cardiovascular Disease: Is There Evidence to Support the Bandwagon?

verfasst von: Giovanni Annuzzi, Giuseppe Della Pepa, Claudia Vetrani

Erschienen in: Current Atherosclerosis Reports | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

In the last 3 years, more evidence accumulated that vitamin D (vitD)deficiency associates with cardiovascular disease (CVD) and risk factors. The association with higher cardiovascular (CV) mortality was stronger than with nonfatal CVD events. A higher incidence of type 2 diabetes was also shown. Many factors related to lifestyle (physical activity in particular) influence both vitD levels and CVD, and may contribute to explain these observational data. Whether the association between vitD and CVD is causal can only be established through randomized controlled trials (RCTs), and to date the results of the randomized trials, which were not designed for investigating CV outcomes, do not support the association data. Answers on the effects of vitD supplementation on primary and secondary prevention of CV may be found in the specifically designed ongoing RCTs. In the mean time, low vitamin D levels should be regarded as a marker of unhealthy lifestyle, requiring a more aggressive attempt at modifying individual lifestyle.

Pilz S, Tomaschitz A, Drechsler C, et al. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res. 2010;54:1103–13.PubMed

Nair R, Maseeh A. Vitamin D: the “sunshine” vitamin. J Pharmacol Pharmacother. 2012;3(2):118–26.PubMed

Ginde AA, Scragg R, Schwartz RS, et al. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009;57:1595–603.PubMedCrossRef

• Kilkkinen A, Knekt P, Aro A, et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009;170:1032–9. Cardiovascular mortality during a 27-year follow-up was investigated in a large nationally representative population sample of men and women free from CVD (Mini-Finland Health Survey). Detailed data on multiple CVD risk factors at baseline are provided. After adjustment for potential confounders, the hazard ratio for total CVD death was significantly lower (0.76) for the highest quintile of baseline serum 25(OH)D level versus the lowest. The association was significant for cerebrovascular death, but not coronary death..PubMedCrossRef

Michaelsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr. 2010;92:841–8.PubMedCrossRef

Durup D, Jørgensen HL, Christensen J, et al.: A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice, the CopD Study. J Clin Endocrinol Metab. 2012;97:2644–52.

Thomas GN, ó Hartaigh B, Bosch JA. Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Diabetes Care. 2012;35(5):1158–64.PubMedCrossRef

Park S, Lee BK. Vitamin D deficiency is an independent risk factor for cardiovascular disease in Koreans aged ≥50 years: results from the Korean National Health and Nutrition Examination Survey. Nutr Res Pract. 2012;6(2):162–8.PubMedCrossRef

Deleskog A, Piksasova O, Silveira A, et al. Serum 25-hydroxyvitamin D concentration, established and emerging cardiovascular risk factors and risk of myocardial infarction before the age of 60 years. Atherosclerosis. 2012;223:223–9.

10.

Knox S, Welsh P, Bezlyak V, et al. 25-Hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid. Atherosclerosis. 2012;223:-437–41.

11.

Kojima G, Bell C, Abbott RD, et al.: Low Dietary Vitamin D Predicts 34-Year Incident Stroke: The Honolulu Heart Program. Stroke 2012;43:2163–7.

12.

Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106:963–8.PubMedCrossRef

13.

Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307–14.PubMed

14.

Pittas AG, Sun Q, Manson JE, et al. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care. 2010;33:2021–3.PubMedCrossRef

15.

Liu E, Meigs JB, Pittas AG, et al. Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr. 2010;91:1627–33.PubMedCrossRef

16.

Grimnes G, Emaus N, Joakimsen RM, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994–95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med. 2010;27:1107–15.PubMedCrossRef

17.

Robinson JG, Manson JE, Larson J, et al. Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care. 2011;34:628–34.PubMedCrossRef

18.

Gagnon C, Lu ZX, Magliano DJ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care. 2011;34:1133–8.PubMedCrossRef

19.

Thorand B, Zierer A, Huth C, et al. Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/ KORA Augsburg study. Diabetes Care. 2011;34:2320–2.PubMedCrossRef

20.

González-Molero I, Rojo-Martinez G, Morcillo S, et al. Vitamin D and incidence of diabetes: a prospective cohort study. Clin Nutr. 2012;31:571–3.

21.

Forouhi NG, Rickard AP, Khaw KT, et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia. 2012;55:2173–82.

22.

Pilz S, van den Hurk K, Nijpels G, et al. Vitamin D status, incident diabetes and prospective changes in glucose metabolism in older subjects: The Hoorn study. Nutr Metab Cardiovasc Dis. 2012;22(10)

23.

Husemoen LL, Thuesen BH, Fenger M, et al.: Serum 25(OH)D and Type 2 Diabetes Association in a General Population: A prospective study. Diabetes Care. 2012;35:1695–700.

24.

Jorde R, Figenschau Y, Emaus N, et al. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension. 2010;55:792–8.PubMedCrossRef

25.

Wang Y, Jacobs EJ, McCullough ML, et al. Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin D. Am J Epidemiol. 2009;170:88–94.PubMedCrossRef

26.

•• Jääskeläinen T, Knekt P, Marniemi J, et al.: Vitamin D status is associated with sociodemographic factors, lifestyle and metabolic health. Eur J Nutr. Published online: 27 April 2012. The Health 2000 Survey, a cross-sectional analysis on 5,174 Finnish men and women, shows how serum 25(OH)D concentration associates with a large number of sociodemographic factors, lifestyle, and metabolic health. Individuals with the healthiest lifestyle estimated by a lifestyle index based on body mass index, physical activity, smoking, alcohol consumption, and diet had 15.8 nmol/l higher serum 25(OH)D concentration compared to those with the unhealthiest lifestyle.

27.

Tomaschitz A, Pilz S, Ritz E, et al. Independent association between 1 25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Clin Chim Acta. 2010;411:1354–60.PubMedCrossRef

28.

Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010;55:1283–8.PubMedCrossRef

29.

Jablonski KL, Chonchol M, Pierce GL, et al. 25-Hydroxyvitamin D Deficiency Is Associated With Inflammation-Linked Vascular Endothelial Dysfunction in Middle-Aged and Older Adults. Hypertension. 2011;57:63–9.PubMedCrossRef

30.

Baker RG, Hayden MS, Ghosh S. NF-kappa B, inflammation, and metabolic disease. Cell Metab. 2011;13:11–22.PubMedCrossRef

31.

Brouwer-Brolsma EM, Feskens EJM, Steegenga WT, de Groot LCPGM: Associations of 25-hydroxyvitamin D with fasting glucose, fasting insulin, dementia and depression in European elderly: the SENECA study. Eur J Nutr. Published online: 23 June 2012.

32.

• Muscogiuri G, Sorice GP, Prioletta A, et al. .25-Hydroxyvitamin D concentration correlates with insulin sensitivity and BMI in obesity. Obesity (Silver Spring). 2010;18:1906–10. In this study, the golden standard for the measurement of insulin sensitivity, i.e. hyperinsulinemic euglycemic clamp, was utilized in individuals with no known history of diabetes. At multivariate analysis BMI was the most powerful predictor of serum 25(OH)D concentration (r = −0.52; p < 0.01), whereas insulin-sensitivity was not significantly associated, indicating the lack of an independent relationship between vitD and insulin-resistance.CrossRef

33.

Kim TN, Park MS, Lim KI, et al. Relationships between Sarcopenic Obesity and Insulin Resistance, Inflammation, and Vitamin D Status: the Korean Sarcopenic Obesity Study (KSOS). Clin Endocrinol. 2012 May 7. [Epub ahead of print]

34.

Weiler HA, Lowe J, Krahn J, Leslie WD. Osteocalcin and vitamin D status are inversely associated with homeostatic model assessment of insulin resistance in Canadian Aboriginal and white women: the First Nations Bone Health Study. J Nutr Biochem 2012. Epub ahead of print.

35.

•• LaCroix AZ, Kotchen J, Anderson G, et al. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women health initiative calcium – vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2009;64(5):559–67. The Women’s Health Initiative Calcium-Vitamin D is by large the biggest trial to date to have investigated the effect of vitamin D on mortality, although it was not designed for this purpose. It randomized 36,282 postmenopausal women to either 400 IU of vitamin D ₃ + 1 g calcium daily or placebo with an average follow-up of 7 years. Non-significant trends toward decreases in overall mortality and CV death (HR 0.92, CI = 0.77–1.10) were observed in the supplementation group, but the effects of Ca and vitamin D could not be differentiated.PubMedCrossRef

36.

•• Bjelakovic G, Gluud LL, Nikolova D, et al.: Vitamin D supplementation for prevention of mortality in adults. Cochrane Database of Syst Rev 2011, July 6, Issue 7. A meta-analysis of The Cochrane Collaboration on 42,589 participants in ten trials showing that vitD supplementation for a median duration of two years compared to no treatment or placebo had no significant effect on CV mortality (RR 1.01, CI = 0.91–1.13). This meta-analysis also showed that vitamin D ₃ reduced all-cause mortality by about 6 % predominantly in elderly women.

37.

Gepner AD, Ramamurthy R, Krueger DC, et al. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One. 2012;7(5):e36617.PubMedCrossRef

38.

Witham MD, Dove FJ, Khan F, et al. Effects of Vitamin D supplementation on markers of vascular function after myocardial infarction—A randomised controlled trial. Int J Cardiol. 2012. 10.1016/j.ijcard.2012.03.054.

39.

Witham MD, Dove FJ, Dryburgh M, et al. The effect of different doses of vitamin D₃ on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2010;53:2112–9.PubMedCrossRef

40.

Rajpathak SN, Xue X, Wassertheil-Smoller S, et al. Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women’s Health Initiative. Am J Clin Nutr. 2010;91:894–9.PubMedCrossRef

41.

Jorde R, Sneve M, Torjesen P, et al. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D₃ for 1 year. J Intern Med. 2010;267:462–72.PubMedCrossRef

42.

Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr. 2009;48:349–54.PubMedCrossRef

43.

Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009;89:1321–7.PubMedCrossRef

44.

Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D₃ supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 2009;26:19–27.PubMedCrossRef

45.

Witham MD, Nadir A, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009;27:1948–54.PubMedCrossRef

46.

Ardabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res. 2012;32:195–201.PubMedCrossRef

47.

von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial. Br J Nutr. 2010;103:549–55.CrossRef

48.

Bock G, Priet B, Mader JK, et al. The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev. 2011;27:942–5.PubMedCrossRef

49.

Harris SS, Pittas AG, Palermo NJ: A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab 2012;14:789–94.

50.

George PS, Pearson ER, Witham MD.: Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 2012;59:e142–e150.

Titel: Vitamin D and Cardiovascular Disease: Is There Evidence to Support the Bandwagon?
verfasst von: Giovanni Annuzzi
Giuseppe Della Pepa
Claudia Vetrani
Publikationsdatum: 01.12.2012
Verlag: Current Science Inc.
Erschienen in: Current Atherosclerosis Reports / Ausgabe 6/2012
Print ISSN: 1523-3804
Elektronische ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-012-0281-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2012

Gastrointestinal Surgery: Cardiovascular Risk Reduction and Improved Long-Term Survival in Patients with Obesity and Diabetes

Bariatric/Metabolic Surgery: Short- and Long-Term Safety

Unprocessed Red and Processed Meats and Risk of Coronary Artery Disease and Type 2 Diabetes – An Updated Review of the Evidence

Alcohol Intake Revisited: Risks and Benefits

Impact of Gastrointestinal Surgery on Cardiometabolic Risk